Stock Rating Downgrade
Recently the Value Trend Rating for Adverum Biotechnologies Inc (NASDAQ: ADVM) weakened from C to D reflecting eroding fundamentals and low Appreciation Potential.
Recent Price Action
Adverum Biotechnologies Inc (NASDAQ: ADVM) stock closed at $5.10 on 3/21/25 after a large decline of -8.9%. Trading volume in this decline was normal. The stock has risen 13.3% during the last week but has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Adverum Biotechnologies has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects very contradictory signals from PTR's two proprietary measures of a stock's attractiveness. Adverum Biotechnologies has a good Appreciation Score of 75 but a very low Power Rating of 9, and the Negative Value Trend Rating results.